These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27039127)

  • 1. Digoxin Toxicity and Use of Digoxin Immune Fab: Insights From a National Hospital Database.
    Hauptman PJ; Blume SW; Lewis EF; Ward S
    JACC Heart Fail; 2016 May; 4(5):357-64. PubMed ID: 27039127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac glycosides, digoxin toxicity, and the antidote.
    Felicilda-Reynaldo RF
    Medsurg Nurs; 2013; 22(4):258-61. PubMed ID: 24147325
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020.
    Peters AE; Chiswell K; Hofmann P; Ambrosy A; Fudim M
    Am J Cardiol; 2022 Nov; 183():129-136. PubMed ID: 36089419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.
    DiDomenico RJ; Walton SM; Sanoski CA; Bauman JL
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):77-85. PubMed ID: 11150387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin use and digoxin toxicity in the post-DIG trial era.
    Hussain Z; Swindle J; Hauptman PJ
    J Card Fail; 2006 Jun; 12(5):343-6. PubMed ID: 16762795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.
    Lapostolle F; Borron SW; Verdier C; Arnaud F; Couvreur J; Mégarbane B; Baud F; Adnet F
    Intensive Care Med; 2008 Aug; 34(8):1448-53. PubMed ID: 18389220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar.
    Rahhal AA; Awaisu A; Tawengi KM; AbuYousef S; Mekideche L
    Int J Clin Pharm; 2017 Oct; 39(5):1070-1083. PubMed ID: 28823072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin.
    Ujhelyi MR; Robert S; Cummings DM; Colucci RD; Green PJ; Sailstad J; Vlasses PH; Zarowitz BJ
    Ann Intern Med; 1993 Aug; 119(4):273-7. PubMed ID: 8328735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focus on digitalis intoxication in the elderly. Report of a case treated with digoxin-specific Fab antibody fragments].
    Pautas É; Lopez C; Gouronnec A; Gravelaine S; Peyron I; Lapostolle F
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Dec; 10(4):355-63. PubMed ID: 23250015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy.
    Georgiopoulou VV; Kalogeropoulos AP; Giamouzis G; Agha SA; Rashad MA; Waheed S; Laskar S; Smith AL; Butler J
    Circ Heart Fail; 2009 Mar; 2(2):90-7. PubMed ID: 19808323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database.
    Hauptman PJ; Swindle J; Burroughs TE; Schnitzler MA
    Am Heart J; 2008 Jun; 155(6):978-985.e1. PubMed ID: 18513507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning.
    Lapostolle F; Borron SW; Verdier C; Taboulet P; Guerrier G; Adnet F; Clemessy JL; Bismuth C; Baud FJ
    Crit Care Med; 2008 Nov; 36(11):3014-8. PubMed ID: 18824911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin toxicity.
    Thacker D; Sharma J
    Clin Pediatr (Phila); 2007 Apr; 46(3):276-9. PubMed ID: 17416888
    [No Abstract]   [Full Text] [Related]  

  • 14. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin measurements following plasma ultrafiltration in two patients with digoxin toxicity treated with specific Fab fragments.
    George S; Braithwaite RA; Hughes EA
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():380-2. PubMed ID: 7979107
    [No Abstract]   [Full Text] [Related]  

  • 16. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
    Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
    Chan BS; Isbister GK; O'Leary M; Chiew A; Buckley NA
    Clin Toxicol (Phila); 2016 Jul; 54(6):488-94. PubMed ID: 27118413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine.
    Ehle M; Patel C; Giugliano RP
    Crit Pathw Cardiol; 2011 Jun; 10(2):93-8. PubMed ID: 21988950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin specific antibody fragments (Digibind) in digoxin toxicity.
    Ip D; Syed H; Cohen M
    BMJ; 2009 Sep; 339():b2884. PubMed ID: 19729422
    [No Abstract]   [Full Text] [Related]  

  • 20. Digoxin: current use and approach to toxicity.
    Vivo RP; Krim SR; Perez J; Inklab M; Tenner T; Hodgson J
    Am J Med Sci; 2008 Nov; 336(5):423-8. PubMed ID: 19011400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.